Adage Capital Partners Gp, L.L.C. Ptc Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$54.6 Billion
Q3 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 250,000 shares of PTCT stock, worth $10.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

250,000

Previous 300,000 16.67%

Holding current value

$10.6 Million

Previous $9.17 Million 1.1%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$30.39 - $37.66 $1.52 Million - $1.88 Million	-50,000 Reduced 16.67%	250,000 $9.28 Million
Q2 2024 Aug 14, 2024	SELL	$24.69 - $40.12 $23.9 Million - $38.9 Million	-970,000 Reduced 76.38%	300,000 $9.17 Million
Q1 2024 May 15, 2024	BUY	$24.15 - $31.95 $9.12 Million - $12.1 Million	377,762 Added 42.34%	1,270,000 $36.9 Million
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $13.4 Million - $21.8 Million	742,238 Added 494.83%	892,238 $24.6 Million
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $11.8 Million - $22.2 Million	-528,247 Reduced 77.88%	150,000 $3.36 Million
Q2 2023 Aug 14, 2023	SELL	$40.4 - $59.1 $47.2 Million - $69.1 Million	-1,168,753 Reduced 63.28%	678,247 $27.6 Million
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $70.5 Million - $90.2 Million	1,847,000 New	1,847,000 $89.5 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $1.88 Million - $2.42 Million	-45,000 Reduced 75.0%	15,000 $753,000
Q2 2022 Aug 15, 2022	SELL	$25.6 - $45.23 $1.79 Million - $3.17 Million	-70,000 Reduced 53.85%	60,000 $2.4 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $4.33 Million - $5.8 Million	130,000 New	130,000 $4.85 Million
Q1 2019 May 15, 2019	SELL	$28.09 - $39.49 $337,080 - $473,880	-12,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $2.24 Million - $3.49 Million	-75,000 Reduced 86.21%	12,000 $412,000
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $2.95 Million - $4.16 Million	87,000 New	87,000 $4.09 Million

Others Institutions Holding PTCT

# of Institutions

219

Shares Held

78.2M

Call Options Held

111K

Put Options Held

30.6K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Ptc Therapeutics, Inc. Transaction History